Search clinical trials for: Plasmacytoid Dendritic Cells

Total 11616 results

Radboud University Medical Center
Rotterdam Eye Hospital

Terminated

Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Uveal Melanoma

Netherlands
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

Prostate Cancer

Czechia
Istituto Scientifico Romagnolo per lo Studio e...

Withdrawn

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC (RENALVax-2)

Carcinoma, Renal Cell | Secondary | Vaccination

Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Leukemia, Myelocytic, Acute

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Immunex Corporation

Withdrawn

Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia
University of North Carolina, Chapel Hill

Completed

Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

Multiple Sclerosis

United States
Leo W. Jenkins Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
Ludwig-Maximilians - University of Munich

Completed

DC Vaccination for Postremission Therapy in AML

Acute Myeloid Leukemia

Germany
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Completed

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
University of Rostock

Unknown

Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma

Severe Eosinophilic Asthma

Germany
M.D. Anderson Cancer Center
ImmunoGen, Inc.

Completed

An Open-label Phase II Study of Lorvotuzumab Mertansine

Leukemia

United States
Northwest Biotherapeutics
Mayo Clinic

Unknown

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

Lung Cancer Metastatic | Brain Metastases | Breast Cancer Metastatic

United States
University of Louisville

Terminated

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Neuroectodermal Tumors, Primitive | Medulloblastoma | Gliomas

United States
Fundació Sant Joan de Déu
Institut d'Investigacions Biomèdiques August Pi i Sunyer

Unknown

Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines

Diffuse Intrinsic Pontine Glioma

Spain
Frank Lieberman
Oncovir, Inc.

Completed

Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

Malignant Glioma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation

Healthy

United States
Dendreon

Completed

PROvenge Treatment and Early Cancer Treatment (PROTECT)

Prostate Cancer

United States
Masonic Cancer Center, University of Minnesota

Completed

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Glioblastoma | Brain Tumor | Ependymoma | Medulloblastoma | Anaplastic Astrocytoma

United States
Penn State University

Withdrawn

A Vaccine Study for High Risk Cancers

Neuroblastoma | Osteogenic Sarcoma | Rhabdomyosarcoma
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (GeniusVac-Mel4)

Melanoma | Effects of Immunotherapy | Tumor Vaccines

France
Clinica Universidad de Navarra, Universidad de...
Centro de Investigación Médica Aplicada (CIMA)

Terminated

Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C

Hepatitis C, Chronic
Clinica Universidad de Navarra, Universidad de...

Unknown

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Colorectal Carcinoma | Hepatic Metastasis

Spain
NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Personalized Immunotherapy of Glioblastoma

Glioblastoma

Russian Federation
NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Neoplasm Metastasis

Russian Federation
NeuroVita Clinic
Blokhin's Russian Cancer Research Center; Russian Foundation of Technological... and other collaborators

Unknown

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Neoplasm Metastasis

Russian Federation
National Cancer Institute (NCI)

Terminated

p53 Vaccine for Ovarian Cancer

Ovarian Neoplasm

United States
Pawel Kalinski
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Andrew D. Luster, M.D.,Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma (MGH-002)

Asthma | Allergies

United States
John Kirkwood
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Dendritic Cells (DC) Vaccine for Metastatic Melanoma

Metastatic Melanoma

United States
BGI, China
Fujian Cancer Hospital

Unknown

TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor

Tumor Gastric | Tumor, Colorectal
The First Affiliated Hospital of Dalian Medical...

Completed

The Relationship of Change of Dendritic Cells Fractalkine and P-selectin Patients With Acute Myocardial Infarction

Acute Myocardial Infarction

China
Research Institute of Fundamental and Clinical...

Unknown

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Colorectal Cancer

Colorectal Cancer

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

HIV Infection

United States
Guiyang Medical University

Unknown

the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Susan G. Komen Breast Cancer Foundation

Terminated

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Baylor Research Institute
Mary Crowley Medical Research Center; ODC Therapy

Completed

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

Melanoma | Neoplasm Metastasis

United States
Baylor Research Institute
French National Agency for Research on AIDS and Viral Hepatitis

Completed

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

HIV

United States
Baylor Research Institute

Withdrawn

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

Lymphoma
Dendreon

Terminated

Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Prostate Cancer

United States
Dendreon

Completed

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Prostate Cancer | Prostatic Neoplasm | Prostatic Adenocarcinoma

United States
Dendreon

Terminated

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

Urothelial Carcinoma

United States
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

Prostate Cancer

Czechia
Weill Medical College of Cornell University

Completed

Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals

Healthy
SOTIO a.s.

Completed

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic

Czechia
Universitair Ziekenhuis Brussel
RIZIV

Completed

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma (DC-MEL)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

Belgium
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Prostate Cancer

Czechia
Dendreon

Completed

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Prostate Cancer

United States
Dendreon

Completed

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Prostate Cancer

United States
University of Louisville

Withdrawn

Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation (AML)

Acute Myelogenous Leukemia

United States

Search clinical trials for: Plasmacytoid Dendritic Cells

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations